In this webinar, Jeffrey Silva, PhD, Principal Scientist in the Proteomics Group at Cell Signaling Technology, will provide an overview of how mass spectrometry-based proteomics can be used for drug discovery and development. Dr. Silva will also present several case studies highlighting how these techniques can be used to gain a deeper understanding of disease mechanisms and as a powerful tool for drug discovery.
Visit the Proteomics Analytics Services resource center for more information.
